Prism Medico and Pharmacy Ltd

Dematerialisation processing and listing

• Dematerialisation requests received during the period were confirmed to the depositories by the RTA.
• Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification, with the depository's name substituted as registered owner.

Upcoming quarter NCS obligations

• No NCS payments due in the Oct–Dec 2026 quarter.

Prism Medico and Pharmacy Limited: Trading window closed from October 01, 2026 and will be re-opened 48 hours after the declaration of the financial results for the quarter and half year ended September 30, 2026

AGM details

• AGM held on 19 September 2026 at 12:30 PM via VC/OAVM.
• Voting cut-off date: 12 September 2026.
• Remote e-voting period: 16–18 September 2026; AGM voting concluded 19 September 2026.
• Mode: Video Conferencing/Other Audio Visual Means from registered office.

Key resolutions and outcomes

• Item 1: Standalone financials adopted; ordinary resolution passed.
• Item 2: Director re-appointment by rotation; ordinary resolution passed.
• Item 3: Statutory auditors re-appointed; remuneration fixed; ordinary resolution passed.
• Item 4: Secretarial auditors appointed for five years; ordinary resolution passed.
• Item 5: Variation in objects of preferential issue and proceeds utilisation; special resolution passed.
• Item 6: Investment in Infuze Well Private Limited; special resolution passed.
• Item 7: Related party subscription of equity shares; ordinary resolution passed.
• Item 8: Related party transactions with Infuze Well Private Limited; ordinary resolution passed.

Director and governance changes

• Director Davender Singh re-appointed; retires by rotation.

Related party transactions

• Investment approved as a related party transaction with Infuze Well Private Limited.
• Related party transactions with Infuze Well Private Limited approved.

AGM Proceedings Summary

• AGM held 19 September 2026 via VC/OAVM, chaired by Sakshi Laller.
• Shareholders on record date 12 September 2026: 4220.
• Ordinary Business: to adopt standalone financial statements for year ended 31 March 2026.
• To re-appoint Mr. Davender Singh as director, retiring by rotation.
• Re-appoint Garg Mendiratta and Associates as statutory auditors, with remuneration fixed.
• Appoint SDK & Associates as Secretarial Auditors for five years (FY2026-27 to FY2030-31).
• Approve variation in the objects of the preferential issue and its utilisation.
• Approve investment of funds in Infuze Well Private Limited under Section 186.
• Approve related party transactions.
• Voting results to be communicated after Scrutinizer's report.

AGM Details

• AGM held on 19 September 2026 at 12:30 PM via Video Conferencing/Other Audio-Visual Means.

Ordinary Resolutions

• Adopt audited standalone financial statements for the year ended March 31, 2026.
• Re-appoint Director Davender Singh by rotation.
• Re-appoint Garg Mendiratta and Associates as statutory auditors; fix remuneration.

Special Resolutions

• Appoint SDK & Associates as Secretarial Auditors for five financial years (2026-27 to 2030-31).
• Approve variation in objects of the preferential issue and utilization of proceeds.
• Approve investment of funds in Infuze Well Private Limited under Section 186.
• Approve material related party transaction: subscription to Infuze Well Private Limited equity shares.
• Approve related party transactions.

Directors & Auditors

• Director changes: Davender Singh re-appointed by rotation.
• Auditor changes: Garg Mendiratta & Associates re-appointed; Secretarial Auditor appointed (SDK & Associates).

Related Party Transactions

• Material RPTs approved: strategic investment in Infuze Well Private Limited.

Book closure and AGM details

• Book closure from 13 September 2026 to 19 September 2026 (both days inclusive) for the AGM.
• Purpose: Annual General Meeting.
• Record date for e-voting: 12 September 2026.
• Remote e-voting starts 16 September 2026 at 09:00 AM.
• Remote e-voting ends 18 September 2026 at 05:00 PM.
• AGM scheduled for 19 September 2026 at 12:30 PM.
• Security type: equity shares.

IWPL investment and preferential issue variation

• Variation in objects of the preferential issue to fund acquisition of IWPL and create a subsidiary.
• Revised object: invest up to Rs 23 crore in IWPL via equity subscription; proceeds contingent on warrant exercise.
• IWPL project: LVP facility at Naraingarh, Haryana; capacity about 5.58 crore units; project ongoing.
• Prism to hold up to 71.32% of IWPL on a fully diluted basis; IWPL to become subsidiary.
• Funding source: proceeds from the May 5, 2026 preferential issue; variation subject to balance realized; no debt.
• Original objects discontinued; investment in IWPL replaces relevant allocations.
• Investment to be completed in one or more tranches within 24 months from approval.
• IWPL is related party; Sakshi Laller is promoter of IWPL; related parties abstain from voting.
• Value exceeds materiality threshold of 10% of turnover (Rs 24.70 lakh).
• Deviation/Variation to be disclosed to Audit Committee and stock exchanges; directors' report and annual report to reflect utilisation.

AGM Details

• AGM scheduled for 19 September 2026 at 12:30 PM via VC/OAVM.
• Record/Book closure from 13 to 19 September 2026 (inclusive).

Resolutions

• Resolution 1 (Ordinary): Adopt audited standalone financial statements and reports.
• Resolution 2 (Ordinary): Re-appoint Davender Singh as director on rotation.
• Resolution 3 (Ordinary): Re-appoint Garg Mendiratta and Associates as statutory auditors; remuneration to be fixed.
• Resolution 4 (Ordinary): Appoint SDK & Associates as Secretarial Auditors for five years.
• Resolution 5 (Special): Vary objects of the preferential issue and utilisation of proceeds.
• Resolution 6 (Special): Invest funds in Infuze Well Private Limited under Section 186.
• Resolution 7 (Ordinary): Approve material related party transaction — Infuze Well subscription.
• Resolution 8 (Ordinary): Approve related party transactions up to Rs 70 crores.

Director Changes

• Re-appoint Davender Singh (DIN: 09447213) as director.

Auditor Appointments

• Statutory auditors Garg Mendiratta and Associates to hold office until next AGM.
• Secretarial auditors M/S SDK & Associates to serve for five years (FY 2026-27 to 2030-31).

Material Related Party Transactions

• IWPL investment: subscription to up to 2.30 million equity shares for up to Rs 23 crore.
• IWPL to become subsidiary; Prism to hold ~71.32% post-issue on fully diluted basis.
• Promoter group: Sakshi Laller promoter of IWPL; pre-issue 19.40% share.
• Funding from preferential issue proceeds; not from existing IWPL shareholders.
• Valuation: Rs 10 per IWPL share by independent valuer.

Voting Results

• Voting results not disclosed in filing.

Key approvals and actions

• Director's Report for FY ended 31 March 2026 approved.
• Notice for the 24th AGM scheduled 19 September 2026 at 12:30 PM via VC approved.
• Register of Members and Share Transfer Books closed 13–19 September 2026 for AGM.
• Record date for electronic voting fixed at 12 September 2026.
• Mast Ram Chechi appointed Scrutinizer for e-voting at AGM.
• Re-appointment of Garg Mendiratta and Associates as Statutory Auditors; remuneration fixed.
• Appointed SDK & Associates as Secretarial Auditors for 2026-27 to 2030-31.
• Investments to be made as per Section 186 of the Companies Act 2013.
• Variation in objects and utilization of proceeds of the Preferential Issue approved.